COWEN AND COMPANY, LLC - EUCRATES BIOMEDICAL ACQU COR ownership

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$8,196
+20.6%
202,371
+65.5%
0.00%0.0%
Q4 2022$6,797
+35.9%
122,2570.0%0.00%
Q3 2022$5,000
-37.5%
122,2570.0%0.00%
-100.0%
Q2 2022$8,000
-77.1%
122,257
-34.7%
0.00%
-66.7%
Q1 2022$35,000
-66.0%
187,227
+5.0%
0.00%
-66.7%
Q4 2021$103,000
+281.5%
178,347
+375.9%
0.01%
+800.0%
Q3 2021$27,000
-30.8%
37,4780.0%0.00%
-50.0%
Q2 2021$39,000
-35.0%
37,478
-21.8%
0.00%
-50.0%
Q1 2021$60,00047,9220.00%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q2 2023
NameSharesValueWeighting ↓
Altium Capital Management LP 133,333$107,0000.03%
EcoR1 Capital, LLC 66,666$652,0000.02%
Monashee Investment Management LLC 99,998$71,0000.01%
Radcliffe Capital Management, L.P. 33,333$326,0000.01%
Granite Point Capital Management, L.P. 133,332$107,0000.01%
683 Capital Management, LLC 200,000$142,0000.01%
KINGDON CAPITAL MANAGEMENT, L.L.C. 66,665$48,0000.01%
CVI Holdings, LLC 118,333$85,0000.01%
AQR Arbitrage LLC 45,832$33,0000.00%
COWEN AND COMPANY, LLC 37,478$27,0000.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders